Prosecution Insights
Last updated: August 18, 2026

Examiner: VALLE, ERNESTO

Tech Center 1600 • Art Units: 1623 1625 1654

This examiner grants 56% of resolved cases

Performance Statistics

56.0%
Allow Rate
-4.0% vs TC avg
80
Total Applications
+41.3%
Interview Lift
1271
Avg Prosecution Days
Based on 25 resolved cases, 2023–2026

Rejection Statute Breakdown

0.4%
§101 Eligibility
20.7%
§102 Novelty
40.1%
§103 Obviousness
26.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17787828 Protein Tyrosine Phosphatase Degraders and Methods of Use Thereof Non-Final OA ABBVIE INC.
17789019 TARGETING THE INTRINSIC APOPTOTIC MACHINERY IN GLIOBLASTOMA Final Rejection The Regents of The University Of California
18286446 COMPOSITION FOR PROMOTING LIPOLYSIS Non-Final OA SUNTORY HOLDINGS LIMITED
18569323 TRAP1 INHIBITOR AND USE THEREOF Non-Final OA UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY)
18270969 METHODS AND MATERIALS FOR TREATING BONE LOSS Non-Final OA The Penn State Research Foundation

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month